The frequency of T regulatory cells is increased in peripheral blood of patients with colon-rectal cancer
Article Sidebar
Published:
Jan 30, 2011
Abstract Book
Issue
Keywords
regulatory T cells, colon-rectal cancer
Statistics
Abstract Views: 383
PDF: 221
PDF: 221
Share it
PlumX Metrics
PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.
How to Cite
Saverino, D., Stabilini, C., SImone, R., Gianetta, E., & Milintenda-Florian, F. (2011). The frequency of T regulatory cells is increased in peripheral blood of patients with colon-rectal cancer. Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale, 84(1). https://doi.org/10.4081/jbr.2011.4659
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Main Article Content
Abstract
Immune system can recognise the tumor-associated antigens present in peripheal blood of cancer patients. Recent studies suggest that CD4+CD25+ regulatory T cells (Treg) might hamper effective immune-surveillance of cancer cells and impede effective immune responses to established tumours. The aim of this study is to demonstrate the presence of Treg in the peripheral blood of colon-rectal cancer (CRC) patients. Results indicate an increase frequency of Treg in the peripheral blood of CRC patients. In addition, Treg is able to regulate the in vitro proliferative response to CEA. Thus, these cells could regulate the immunosuppression and, eventually, the neoplastic progression in CRC patients.
Downloads month by month
Downloads
Download data is not yet available.
